To the Editor: Court, Bergh and Södersten raise the issue of why and how some therapies with prima facie evidence for their efficacy have a significant take-up by medical practitioners, while others are allowed to languish, sometimes for decades.1
- Phillip Gray
- Queanbeyan, NSW.
Correspondence: gray.qbn@effect.net.au
Responses are now closed for this article.